Table 3.
Univariate Log Rank and Multivariate Analyses for Disease-Specific and Metastasis-Free Survival in Upper Urinary Tract Urothelial Carcinoma
| Parameter | Category | Case No. | Disease-Specific Survival | Metastasis-Free Survival | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Univariate Analysis | Multivariate Analysis | Univariate Analysis | Multivariate Analysis | |||||||||
| No. of Events | P-value | RR | 95% CI | p-value | No. of Events | p-value | RR | 95% CI | P-value | |||
| Gender | Male | 158 | 28 | 0.8286 | – | – | – | 32 | 0.7904 | – | – | – |
| Female | 182 | 33 | – | – | – | 38 | – | – | – | |||
| Age (years) | <65 | 138 | 26 | 0.9943 | – | – | – | 30 | 0.8470 | – | – | – |
| ≥65 | 202 | 35 | – | – | – | 40 | – | – | – | |||
| Tumor side | Right | 177 | 34 | 0.7366 | – | – | – | 38 | 0.3074 | – | – | – |
| Left | 154 | 26 | – | – | – | 32 | – | – | – | |||
| Bilateral | 9 | 1 | – | – | – | 0 | – | – | – | |||
| Tumor location | Renal pelvis | 141 | 24 | 0.0079* | 1 | – | 0.613 | 31 | 0.0659 | – | – | – |
| Ureter | 150 | 22 | 0.638 | 0.175–2.327 | 25 | – | – | – | ||||
| Renal pelvis and ureter | 49 | 15 | 0.519 | 0.130–2.066 | 14 | – | – | – | ||||
| Multifocality | Single | 273 | 48 | 0.0026* | 1 | – | 0.405 | 52 | 0.0127* | 1 | – | 0.111 |
| Multifocal | 62 | 18 | 2.152 | 0.486–5.965 | 18 | 2.384 | 1.400–3.257 | |||||
| Primary tumor (T) | Ta | 89 | 2 | <0.0001* | 1 | – | 0.078 | 4 | <0.0001* | 1 | – | 0.265 |
| T1 | 92 | 9 | 3.194 | 0.670–15.225 | 15 | 2.577 | 0.826–8.040 | |||||
| T2–T4 | 159 | 50 | 5.297 | 1.156–24.275 | 51 | 2.193 | 0.689–6.979 | |||||
| Nodal metastasis | Negative (N0) | 312 | 42 | <0.0001* | 1 | – | <0.001* | 55 | <0.0001* | 1 | – | 0.001* |
| Positive (N1–N2) | 28 | 19 | 5.148 | 2.782–9.526 | 15 | 2.940 | 1.566–5.518 | |||||
| Histological grade | Low grade | 56 | 4 | 0.0215* | 1 | – | 0.077* | 3 | 0.0027* | 1 | – | 0.066 |
| High grade | 284 | 57 | 2.769 | 0.896–8.554 | 67 | 3.219 | 0.925–11.207 | |||||
| Vascular invasion | Absent | 234 | 24 | <0.0001* | 1 | – | 0.304 | 26 | <0.0001* | 1 | – | 0.030* |
| Present | 106 | 37 | 1.387 | 0.743–2.590 | 44 | 1.994 | 1.070–3.716 | |||||
| Perineural invasion | Absent | 321 | 50 | <0.0001* | 1 | – | <0.001* | 61 | <0.0001* | 1 | – | 0.015* |
| Present | 19 | 11 | 3.774 | 1.767–8.062 | 9 | 2.640 | 1.945–8.516 | |||||
| Mitotic rate (per 10 high-power fields) | < 10 | 173 | 27 | 0.167 | – | – | 30 | 0.0823 | – | – | ||
| ≥ 10 | 167 | 34 | – | – | 40 | – | – | |||||
| COMP expression | Low | 170 | 11 | <0.0001* | 1 | – | 0.027* | 10 | <0.0001* | 1 | – | <0.001* |
| High | 170 | 50 | 2.283 | 1.100–4.735 | 60 | 4.070 | 1.945–8.516 | |||||
Note: *Statistically significant.